Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.00
+0.20 (0.50%)
Jun 4, 2025, 1:30 PM CST
-15.16%
Market Cap 28.67B
Revenue (ttm) 1.63B
Net Income (ttm) -13.57M
Shares Out 720.42M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend 0.75 (1.88%)
Ex-Dividend Date Aug 2, 2024
Volume 857,929
Average Volume 1,110,188
Open 40.00
Previous Close 39.80
Day's Range 39.75 - 40.25
52-Week Range 30.60 - 59.60
Beta 0.40
RSI 63.18
Earnings Date May 12, 2025

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depressi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

In 2024, Center Laboratories's revenue was 1.62 billion, an increase of 16.06% compared to the previous year's 1.39 billion. Losses were -1.10 billion, 10.9% more than in 2023.

Financial Statements

News

There is no news available yet.